Home    Back

Revatio ® 20 mg film-coated tablets    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
86Pulmonary arterial hypertension1

86. Pulmonary arterial hypertension    [ 1,083 clinical trials,   667 drugs,   (DrugBank: 122 drugs),   98 drug target genes,   185 drug target pathways]
Searched query = "Pulmonary arterial hypertension", "PAH", "IPAH", "HPAH", "Eisenmenger syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1,083 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2006-004705-26-GB
(EUCTR)		10/05/200717/04/2007Safety and Tolerability of Sildenafil in Patients with Eisenmenger PhysiologySafety and Tolerability of Sildenafil in Patients with Eisenmenger Physiology Eisenmenger Syndrome (pulmonary hypertension due to congenital heart disease)
MedDRA version: 8.1;Level: LLT;Classification code 10058554;Term: Eisenmenger's syndrome		Trade Name: Revatio ® 20 mg film-coated tablets
Product Name: Sildenafil
INN or Proposed INN: Sildenafil (REVATIO)		Imperial College LondonNULLNot RecruitingFemale: yes
Male: yes		12Phase 4United Kingdom